OF THE DISCLOSURE USE OF A POLYSACCHARIDE MIXTURE FOR TREATING HYPERGLYCEMIA Disclosed herein is a novel use of a polysaccharide mixture for the treatment of hyperglycemia and/or disorders relat ed thereto (e.g., diabetes 5 mellitus). The polysaccharide mixture comprises about 30-50% (wt%) of β(1→3) glucan and β(1→6) glucan, and has a molecular weight of at least 500,000. The polysaccharide mixture may be administered to a subject suffering from hyperglycemia in a dose of about 1 to 1,000 mg/Kg to ameliorate or alleviate symptoms associated with hyperglycemia. 10 (FIG. 4)